Related Experiment Videos
Creatinine is the best molecule to target adequacy of peritoneal dialysis
1Division of Nephrology, University of Western Ontario, London Health Sciences Centre, Canada.
Insights
Neither creatinine clearance nor urea clearance perfectly predicts outcomes in peritoneal dialysis (PD) patients. Creatinine clearance is preferred, but both indices require careful interpretation and clinical judgment due to limitations.
Area of Science:
- Nephrology
- Peritoneal Dialysis
- Renal Function Assessment
Background:
- Assessing patient outcomes in peritoneal dialysis (PD) is crucial.
- Current methods for evaluating solute clearance in PD patients have limitations.
- Residual renal function is a key factor in PD patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of creatinine clearance and urea clearance as predictors of patient outcomes in PD.
- To compare the utility of creatinine clearance versus urea clearance.
- To identify limitations and suggest improvements for clearance measurements in PD.
Main Methods:
- Analysis of patient data to assess the predictive value of creatinine and urea clearance.
- Comparison of the correlation between clearance indices and patient outcomes.
- Evaluation of the impact of normalization methods on clearance measurements.
Main Results:
- Neither creatinine clearance nor urea clearance is a perfect predictor of PD patient outcomes.
- Creatinine clearance is considered a better index than urea clearance due to its emphasis on residual renal function.
- Both indices have limitations, particularly in low transporters and due to conventional normalization methods.
Conclusions:
- Creatinine clearance and urea clearance are imperfect but complementary indices for PD patients.
- Residual renal function, better reflected by creatinine clearance, is a strong predictor of patient outcomes.
- Further research into normalization methods and the interplay with protein intake and lean body mass is warranted, alongside clinical judgment.
Abstract:
The overall conclusion is that neither creatinine clearance nor urea clearance is the perfect index for predicting outcome in PD patients. In the absence of indices that are better validated and more convenient, creatinine and urea are what we have to use. They are best seen as two imperfect, but potentially complementary, measurements. On balance, creatinine clearance is the better of the two indices, in that it gives greater weight to residual renal function, and residual renal function is probably a stronger predictor of patient outcome than peritoneal clearance per se. However, creatinine clearance has a particular weakness in low transporters; values have to be interpreted with discretion in this group. Furthermore, both indices are flawed because of the manner in which they are conventionally normalized. Research into more appropriate methods of normalization, or into whether normalization is required at all, would be helpful. The complex relationship between these clearance indices, protein intake, and lean body mass also needs to be kept in mind. While this paper argues in favour of creatinine clearance as the better index, it still suggests that both indices be used, together with a large measure of clinical judgment.